330 related articles for article (PubMed ID: 23800495)
21. Edaravone for acute stroke: Meta-analyses of data from randomized controlled trials.
Yang J; Cui X; Li J; Zhang C; Zhang J; Liu M
Dev Neurorehabil; 2015; 18(5):330-5. PubMed ID: 24088023
[TBL] [Abstract][Full Text] [Related]
22. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
23. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters.
Edaravone Acute Infarction Study Group
Cerebrovasc Dis; 2003; 15(3):222-9. PubMed ID: 12715790
[TBL] [Abstract][Full Text] [Related]
24. Adverse Influence of Pre-Stroke Dementia on Short-Term Functional Outcomes in Patients with Acute Ischemic Stroke: The Fukuoka Stroke Registry.
Wakisaka Y; Matsuo R; Hata J; Kuroda J; Kitazono T; Kamouchi M; Ago T;
Cerebrovasc Dis; 2017; 43(1-2):82-89. PubMed ID: 27951543
[TBL] [Abstract][Full Text] [Related]
25. Edaravone: a new therapeutic approach for the treatment of acute stroke.
Kikuchi K; Kawahara K; Miyagi N; Uchikado H; Kuramoto T; Morimoto Y; Tancharoen S; Miura N; Takenouchi K; Oyama Y; Shrestha B; Matsuda F; Yoshida Y; Arimura S; Mera K; Tada K; Yoshinaga N; Maenosono R; Ohno Y; Hashiguchi T; Maruyama I; Shigemori M
Med Hypotheses; 2010 Dec; 75(6):583-5. PubMed ID: 20728280
[TBL] [Abstract][Full Text] [Related]
26. Anemia is associated with poor outcomes in patients with less severe ischemic stroke.
Sico JJ; Concato J; Wells CK; Lo AC; Nadeau SE; Williams LS; Peixoto AJ; Gorman M; Boice JL; Bravata DM
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):271-8. PubMed ID: 22100828
[TBL] [Abstract][Full Text] [Related]
27. A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy?
Lapchak PA
Expert Opin Pharmacother; 2010 Jul; 11(10):1753-63. PubMed ID: 20491547
[TBL] [Abstract][Full Text] [Related]
28. Investigation of effect of edaravone on ischemic stroke.
Ishibashi A; Yoshitake Y; Adachi H
Kurume Med J; 2013; 60(2):53-7. PubMed ID: 24291782
[TBL] [Abstract][Full Text] [Related]
29. Acute kidney injury after orthotopic liver transplantation using living donor versus deceased donor grafts: A propensity score-matched analysis.
Hilmi IA; Damian D; Al-Khafaji A; Sakai T; Donaldson J; Winger DG; Kellum JA
Liver Transpl; 2015 Sep; 21(9):1179-85. PubMed ID: 25980614
[TBL] [Abstract][Full Text] [Related]
30. Protective effect of edaravone against renal ischemia/reperfusion injury and compared with ischemic postconditioning in rats.
Li Y; Xia AZ; Xing SH
Yao Xue Xue Bao; 2010 Jul; 45(7):840-8. PubMed ID: 20931780
[TBL] [Abstract][Full Text] [Related]
31. Effect of edaravone on favorable outcome in patients with acute cerebral large vessel occlusion: subanalysis of RESCUE-Japan Registry.
Miyaji Y; Yoshimura S; Sakai N; Yamagami H; Egashira Y; Shirakawa M; Uchida K; Kageyama H; Tomogane Y
Neurol Med Chir (Tokyo); 2015; 55(3):241-7. PubMed ID: 25739433
[TBL] [Abstract][Full Text] [Related]
32. Associations between Uric Acid Level and 3-Month Functional Outcome in Acute Ischemic Stroke Patients Treated with/without Edaravone.
Naganuma M; Inatomi Y; Nakajima M; Yonehara T; Ando Y
Cerebrovasc Dis; 2018; 45(3-4):115-123. PubMed ID: 29558754
[TBL] [Abstract][Full Text] [Related]
33. Low glomerular filtration rate increases hemorrhagic transformation in acute ischemic stroke.
Lee JG; Lee KB; Jang IM; Roh H; Ahn MY; Woo HY; Hwang HW
Cerebrovasc Dis; 2013; 35(1):53-9. PubMed ID: 23428997
[TBL] [Abstract][Full Text] [Related]
34. Edaravone offers neuroprotection for acute diabetic stroke patients.
Zheng J; Chen X
Ir J Med Sci; 2016 Nov; 185(4):819-824. PubMed ID: 26597952
[TBL] [Abstract][Full Text] [Related]
35. Treatment with edaravone attenuates ischemic brain injury and inhibits neurogenesis in the subventricular zone of adult rats after focal cerebral ischemia and reperfusion injury.
Zhang P; Li W; Li L; Wang N; Li X; Gao M; Zheng J; Lei S; Chen X; Lu H; Liu Y
Neuroscience; 2012 Jan; 201():297-306. PubMed ID: 22116052
[TBL] [Abstract][Full Text] [Related]
36. The impact of acute kidney injury on midterm outcomes after coronary artery bypass graft surgery: a matched propensity score analysis.
Gallagher S; Jones DA; Lovell MJ; Hassan S; Wragg A; Kapur A; Uppal R; Yaqoob MM
J Thorac Cardiovasc Surg; 2014 Mar; 147(3):989-95. PubMed ID: 23587469
[TBL] [Abstract][Full Text] [Related]
37. Early Antidepressant Treatment and All-Cause 30-Day Mortality in Patients with Ischemic Stroke.
Mortensen JK; Johnsen SP; Larsson H; Andersen G
Cerebrovasc Dis; 2015; 40(1-2):81-90. PubMed ID: 26184925
[TBL] [Abstract][Full Text] [Related]
38. Free radical scavenger, edaravone, reduces the lesion size of lacunar infarction in human brain ischemic stroke.
Nakase T; Yoshioka S; Suzuki A
BMC Neurol; 2011 Mar; 11():39. PubMed ID: 21447190
[TBL] [Abstract][Full Text] [Related]
39. Determinants for the prognosis of acute renal disorders that developed during or after treatment with edaravone.
Hishida A
Clin Exp Nephrol; 2009 Apr; 13(2):118-122. PubMed ID: 19057980
[TBL] [Abstract][Full Text] [Related]
40. Effect of Edaravone on Neurological Symptoms in Real-World Patients With Acute Ischemic Stroke.
Kobayashi S; Fukuma S; Ikenoue T; Fukuhara S; Kobayashi S
Stroke; 2019 Jul; 50(7):1805-1811. PubMed ID: 31164072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
